search for


Intraoperative cardiopulmonary collapse despite prophylactic anticoagulation for thromboembolism
Med Biol Sci Eng 2018;1(2):61-64
Published online July 31, 2018
© 2018 Medical Biological Science and Engineering.

Ju Deok Kim, Chiachi Cheng, Dong Jin Shim, Doo Sik Kim, Sie Jeong Ryu, Yusom Shin

Department of Anesthesiology and Pain Medicine, Kosin University College of Medicine, Busan, Korea
Correspondence to: Yusom Shin
Department of Anesthesiology and Pain Medicine, Kosin University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 49267, Korea
Tel: +82-51-990-6283
Fax: +82-51-254-2504
Received May 11, 2018; Revised June 2, 2018; Accepted June 4, 2018.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Prophylactic anticoagulation for high-risk patients of pulmonary embolism (PE) prevails as acute PE potentially leads to hemodynamic instability resulting in death. Notwithstanding the adequate thromboprophylaxis, rarely, we may face a patient’s critical condition with PE. We report here on the patient given intraoperative cardiopulmonary resuscitation that the cause was revealed to be PE despite subcutaneous anticoagulant until the day before scheduled secondary operation. The 72-year-old male patient had already undergone first emergency surgery for right tibia and patella fractures without any problems. Albeit effective, prophylaxis for thromboembolism cannot guarantee PE prevention. With this sobering fact in mind, additionally, early diagnosis and prompt management of PE, especially through interdepartmental coordination, should produce patients’ best outcomes.
Keywords : Anticoagulants; Resuscitation; Venous thrombosis; Pulmonary embolism
  1. Kim HJ, Walcott-Sapp S, Leggett K, Bass A, Adler RS, Pavlov H, et al. Detection of pulmonary embolism in the postoperative orthopedic patient using spiral CT scans. HSS J 2010;6:95-8.
    Pubmed CrossRef
  2. Kearon C. Natural history of venous thromboembolism. Circulation 2003;107(23 Suppl 1):I22-30.
  3. Merli GJ. Pathophysiology of venous thrombosis, thrombophilia, and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly. Clin Geriatr Med 2006;22:75-92.
    Pubmed CrossRef
  4. Kumar DR, Hanlin E, Glurich I, Mazza JJ, Yale SH. Virchow’s contribution to the understanding of thrombosis and cellular biology. Clin Med Res 2010;8:168-72.
    Pubmed CrossRef
  5. Leme LE, Sguizzatto GT. Prophylaxis of venous thromboembolism in orthopaedic surgery. Rev Bras Ortop 2015;47:685-93.
    Pubmed CrossRef
  6. Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995;108:978-81.
  7. Geerts WH, Berqqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl):381S453S.
  8. Kakkar AK, Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Deslandes B, et al. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey):findings in surgical patients. Ann Surg 2010;251:330-8.
    Pubmed CrossRef
  9. Schellhaass A, Walther A, Konstantinides S, Böttiger BW. The diagnosis and treatment of acute pulmonary embolism. Dtsch Arztebl Int 2010;107:589-95.
  10. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 2014;35:3033-69, 3069a-3069k.
  11. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation 2003;107(23 Suppl 1):I9-16.
  12. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients:antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e278S325S.
  13. Sociedade Brasileira de Angiologia e Cirurgia Vascular. [Normas de orientação clínica para a prevenção, o diagnóstico e o tratamento da trombose venosa profunda]. J Vasc Br 2005;4(Suppl 3):S205-20. In Brazil.
  14. Yamamoto T. Management of patients with high-risk pulmonary embolism: a narrative review. J Intensive Care 2018;6:16.
    Pubmed CrossRef
  15. Daniels LB, Parker JA, Patel SR, Grodstein F, Goldhaber SZ. Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism. Am J Cardiol 1997;80:184-8.
  16. Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 2014;311:2414-21.
    Pubmed CrossRef
  17. Holmoström M, Berglund MC, Granquist S, Bratt G, Törnebohm E, Lockner D. Fragmin once or twice daily subcutaneously in the treatment of deep venous thrombosis of the leg. Thromb Res 1992;67:49-55.
  18. Bhutia S, Wong PF. Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism. Cochrane Database Syst Rev 2013;(7):CD003074.

January 2019, 2 (1)
Full Text(PDF) Free

Social Network Service

Cited By Articles
  • CrossRef (0)
  • Crossref
  • Google Scholar